Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

(2013) Nicolas Bertrand et al.   ADVANCED DRUG DELIVERY REVIEWS

Nanocarrier-Mediated Targeting of Tumor and Tumor Vascular Cells Improves Uptake and Penetration of Drugs into Neuroblastoma

(2013) Fabio Pastorino et al.   Frontiers in Oncology

Cancer treatment and survivorship statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model

(2012) Donatella Paolino et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Doxil® — The first FDA-approved nano-drug: Lessons learned

(2012) Yechezkel (Chezy) Barenholz   JOURNAL OF CONTROLLED RELEASE

Modified and derived ethanol injection toward liposomes: development of the process

(2012) Philippe Gentine et al.   JOURNAL OF LIPOSOME RESEARCH

Functional Roles of Gangliosides in Neurodevelopment: An Overview of Recent Advances

(2012) Robert K. Yu et al.   NEUROCHEMICAL RESEARCH

Long-term Complications of Therapeutic Exposures in Childhood: Lessons Learned From Childhood Cancer Survivors

(2012) S. Bhatia   PEDIATRICS

Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles

(2012) Amanda Tivnan et al.   PLoS One

Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor

(2012) Sachiko Ezoe   International Journal of Environmental Research and Public Health

Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo

(2012) Nai-Kong V. Cheung et al.   OncoImmunology

Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic Nanomedicine

(2011) Wafa’ T. Al-Jamal et al.   ACCOUNTS OF CHEMICAL RESEARCH

Multistage Nanovectors: From Concept to Novel Imaging Contrast Agents and Therapeutics

(2011) Biana Godin et al.   ACCOUNTS OF CHEMICAL RESEARCH

Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide

(2011) Tiecheng Zhang et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in Neuroblastoma

(2011) Daniela Di Paolo et al.   MOLECULAR THERAPY

Effect of HFE Variants on Sphingolipid Expression by SH-SY5Y Human Neuroblastoma Cells

(2011) F. Ali-Rahmani et al.   NEUROCHEMICAL RESEARCH

Preparation of Targeting Proteoliposome by Postinsertion of a Linker Molecule Conjugated with Recombinant Human Epidermal Growth Factor

(2010) Sang Youn Hwang et al.   BIOCONJUGATE CHEMISTRY

Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs

(2010) Mariano Licciardi et al.   BIOMATERIALS

Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma

(2010) Monica Loi et al.   JOURNAL OF CONTROLLED RELEASE

Antibody derivatization and conjugation strategies: Application in preparation of stealth immunoliposome to target chemotherapeutics to tumor

(2010) Arehalli S. Manjappa et al.   JOURNAL OF CONTROLLED RELEASE

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction

(2009) Elena Posse de Chaves et al.   FEBS LETTERS

Seven challenges for nanomedicine

(2008) Wendy R. Sanhai et al.   Nature Nanotechnology